Korean-Indonesian JV’s MUI halal status for biopharma product derived from animal cells not protected by nat’l halal authority – BPJPH head
JAKARTA – A Korean-Indonesian joint venture has received what is believed to be the world’s first halal certification for a biopharmaceutical product derived from animal cells but the halal status cannot be vouched for by Indonesia’s halal authority.
Daewoong Infion, a JV between Korea Exchange-listed Daewoong Pharmaceutical and Indonesian company Infion, secured halal certification for its Epodion on January 3 from MUI-LPPOM, Chang Woo Suh, its President Director told Salaam Gateway.
Epodion is an anaemia treatment for dialysis patients with kidney failures, and cancer patients. It obtained approval from Indonesia’s National Agency of Drug and Food Control (BPOM) in December 2016 and launched in the country in April 2017.
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
